Sjögren's syndrome (SS) is a systemic autoimmune disease that frequently occurs concomitantly with other systemic connective tissue disorders, including rare and complex diseases such as systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). The presence of SS influences the clinical expression of the other autoimmune diseases, thus offering the unique opportunity to explore the similarities in genetic signatures, as well as common environmental and biologic factors modulating the expression of disease phenotypes. In this review, we will specifically discuss the possibility of defining "SS/SLE" and "SS/SSc" as distinct subsets within the context of connective tissue diseases with different clinical expression and outcomes, thus deserving an individualised assessment and personalised medical interventions.

Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison / C. Baldini, L. Arnaud, T. Avčin, L. Beretta, C. Bellocchi, C. Bouillot, G. Burmester, L. Cavagna, M. Cutolo, J.K. de Vries-Bouwstra, A. Doria, F. Ferro, J.E. Fonseca, S. Fonzetti, G. Fulvio, I. Galetti, J. Gottenberg, E. Hachulla, T. Krieg, G. La Rocca, T. Martin, M. Matucci-Cerinic, P. Moinzadeh, C. Montecucco, M. Mosca, L. Mouthon, U. Müller-Ladner, S. Rednic, V. Smith, R. Talarico, J.M. van Laar, A. Vieira, V.C. Romão, X. Mariette. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 1593-098X. - 40:5(2022 May 18), pp. S103-S112. [10.55563/clinexprheumatol/3y0hqs]

Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison

C. Bellocchi;
2022

Abstract

Sjögren's syndrome (SS) is a systemic autoimmune disease that frequently occurs concomitantly with other systemic connective tissue disorders, including rare and complex diseases such as systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). The presence of SS influences the clinical expression of the other autoimmune diseases, thus offering the unique opportunity to explore the similarities in genetic signatures, as well as common environmental and biologic factors modulating the expression of disease phenotypes. In this review, we will specifically discuss the possibility of defining "SS/SLE" and "SS/SSc" as distinct subsets within the context of connective tissue diseases with different clinical expression and outcomes, thus deserving an individualised assessment and personalised medical interventions.
overlap autoimmune rheumatic diseases; Sjögren's syndrome; systemic lupus erythematosus; systemic sclerosis;
Settore MED/16 - Reumatologia
Settore MED/09 - Medicina Interna
18-mag-2022
21-mar-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
article.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 421.5 kB
Formato Adobe PDF
421.5 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1064929
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact